Quel est le prix pour Zhejiang Tailin BioEngineering Co.,Ltd (300813)

Le prix pour Zhejiang Tailin BioEngineering Co.,Ltd (300813) est $3.07

Quelle est la capitalisation boursière pour Zhejiang Tailin BioEngineering Co.,Ltd (300813)

La capitalisation boursière pour Zhejiang Tailin BioEngineering Co.,Ltd (300813) est $372.52M

Bénéfices de Zhejiang Tailin BioEngineering Co.,Ltd (300813)

Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly active drug development/production, aseptic material transfer, packaging and test equipment, automated production solutions, sterility tests, and sterile connectors; microbiological detection systems; sterility testing systems; biodecontamination and infection control solutions; analytical instruments; quality control solutions, and laboratory animals/scientific research products, as well as active microbial products, and membrane materials. Its products are used in bio-pharmaceuticals, biosafety, disease control, food safety, and other industries. Zhejiang Tailin BioEngineering Co.,Ltd was formerly known as Hangzhou Tailin Biotechnology Equipment Co., Ltd. and changed its name to Zhejiang Tailin BioEngineering Co.,Ltd in April 2015. The company was founded in 1993 and is based in Hangzhou, China.

Année	Bénéfices	Changez
Pas assez de données pour les dates fournies.

Année

Bénéfices

Changez

Pas assez de données pour les dates fournies.

Entreprise	Bénéfices	Différence de bénéfices	Pays
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-	US
Argenx SE ARGX.US	$1.95B	-	NL
CSL Limited CSL.AX	$-4.02B	-	AU
Moderna, Inc. MRNA.US	$-3.09B	-	US
Lonza Group AG LONN.SW	-	-	CH

Entreprise

Bénéfices

Différence de bénéfices

Pays